Literature DB >> 9484807

Expression of alphav integrins and vitronectin receptor identity in breast cancer cells.

T Meyer1, J F Marshall, I R Hart.   

Abstract

In the present study we have used fluorocytometry and immunoprecipitation to characterize the expression of alphav-containing integrins in a panel of eight human breast cancer cell lines and one normal human mammary epithelial line. We show that the classical vitronectin receptor alphavbeta3 is expressed in only one cell line (MDA-MB-231), whereas alphavbeta5 is expressed on all breast cancer cell lines and alphavbeta1 is expressed on the majority. Using adherence assays to purified ligands in the presence and absence of function-blocking monoclonal antibodies, we have demonstrated that alphavbeta5 mediates adhesion to vitronectin in the majority of these cells. In one cell line, ZR75-1, alphavbeta1 contributes significantly to adhesion to immobilized vitronectin. The formation of focal adhesions containing the alphav and beta1 subunits on vitronectin is also demonstrated by indirect immunofluorescence.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9484807      PMCID: PMC2149929          DOI: 10.1038/bjc.1998.86

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  23 in total

Review 1.  The role of alpha v-integrins in tumour progression and metastasis.

Authors:  J F Marshall; I R Hart
Journal:  Semin Cancer Biol       Date:  1996-06       Impact factor: 15.707

Review 2.  Integrins: a family of cell surface receptors.

Authors:  R O Hynes
Journal:  Cell       Date:  1987-02-27       Impact factor: 41.582

3.  A novel vitronectin receptor integrin (alpha v beta x) is responsible for distinct adhesive properties of carcinoma cells.

Authors:  D A Cheresh; J W Smith; H M Cooper; V Quaranta
Journal:  Cell       Date:  1989-04-07       Impact factor: 41.582

4.  The human integrin alpha 8 beta 1 functions as a receptor for tenascin, fibronectin, and vitronectin.

Authors:  L M Schnapp; N Hatch; D M Ramos; I V Klimanskaya; D Sheppard; R Pytela
Journal:  J Biol Chem       Date:  1995-09-29       Impact factor: 5.157

5.  Requirement of receptor-bound urokinase-type plasminogen activator for integrin alphavbeta5-directed cell migration.

Authors:  M Yebra; G C Parry; S Strömblad; N Mackman; S Rosenberg; B M Mueller; D A Cheresh
Journal:  J Biol Chem       Date:  1996-11-15       Impact factor: 5.157

6.  The serpin PAI-1 inhibits cell migration by blocking integrin alpha V beta 3 binding to vitronectin.

Authors:  S Stefansson; D A Lawrence
Journal:  Nature       Date:  1996-10-03       Impact factor: 49.962

7.  The roles of integrins and extracellular matrix proteins in the insulin-like growth factor I-stimulated chemotaxis of human breast cancer cells.

Authors:  M E Doerr; J I Jones
Journal:  J Biol Chem       Date:  1996-02-02       Impact factor: 5.157

8.  Coordinated expression of the vitronectin receptor and the urokinase-type plasminogen activator receptor in metastatic melanoma cells.

Authors:  J Nip; S A Rabbani; H R Shibata; P Brodt
Journal:  J Clin Invest       Date:  1995-05       Impact factor: 14.808

9.  Alpha v beta 1 is a receptor for vitronectin and fibrinogen, and acts with alpha 5 beta 1 to mediate spreading on fibronectin.

Authors:  J F Marshall; D C Rutherford; A C McCartney; F Mitjans; S L Goodman; I R Hart
Journal:  J Cell Sci       Date:  1995-03       Impact factor: 5.285

10.  Multiplicity of fibronectin-binding alpha V integrin receptors in colorectal cancer.

Authors:  M V Agrez; R C Bates; D Mitchell; N Wilson; N Ferguson; P Anseline; D Sheppard
Journal:  Br J Cancer       Date:  1996-04       Impact factor: 7.640

View more
  28 in total

1.  Integrin alpha(v)beta1 is an adenovirus coreceptor.

Authors:  E Li; S L Brown; D G Stupack; X S Puente; D A Cheresh; G R Nemerow
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

2.  A targeted nanoglobular contrast agent from host-guest self-assembly for MR cancer molecular imaging.

Authors:  Zhuxian Zhou; Zhen Han; Zheng-Rong Lu
Journal:  Biomaterials       Date:  2016-02-03       Impact factor: 12.479

3.  Shear stress induced release of von Willebrand factor and thrombospondin-1 in HUVEC extracellular matrix enhances breast tumour cell adhesion.

Authors:  Noëlia Gomes; Chantal Legrand; Françoise Fauvel-Lafève
Journal:  Clin Exp Metastasis       Date:  2005       Impact factor: 5.150

4.  Interfacial activity assisted surface functionalization: a novel approach to incorporate maleimide functional groups and cRGD peptide on polymeric nanoparticles for targeted drug delivery.

Authors:  Udaya S Toti; Bharath Raja Guru; Alex E Grill; Jayanth Panyam
Journal:  Mol Pharm       Date:  2010-08-02       Impact factor: 4.939

5.  Breaking the one antibody-one target axiom.

Authors:  Fang Guo; Sanjib Das; Barbara M Mueller; Carlos F Barbas; Richard A Lerner; Subhash C Sinha
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-05       Impact factor: 11.205

6.  Urokinase receptors promote beta1 integrin function through interactions with integrin alpha3beta1.

Authors:  Y Wei; J A Eble; Z Wang; J A Kreidberg; H A Chapman
Journal:  Mol Biol Cell       Date:  2001-10       Impact factor: 4.138

7.  Myosin light chain kinase functions downstream of Ras/ERK to promote migration of urokinase-type plasminogen activator-stimulated cells in an integrin-selective manner.

Authors:  D H Nguyen; A D Catling; D J Webb; M Sankovic; L A Walker; A V Somlyo; M J Weber; S L Gonias
Journal:  J Cell Biol       Date:  1999-07-12       Impact factor: 10.539

8.  Cilengitide affects tumor compartment, vascularization and microenvironment in experimental bone metastases as shown by longitudinal ¹⁸F-FDG PET and gene expression analysis.

Authors:  Maren Bretschi; Caixia Cheng; Hendrik Witt; Antonia Dimitrakopoulou-Strauss; Ludwig G Strauss; Wolfhard Semmler; Tobias Bäuerle
Journal:  J Cancer Res Clin Oncol       Date:  2012-12-11       Impact factor: 4.553

9.  Foot-and-mouth disease virus receptors: comparison of bovine alpha(V) integrin utilization by type A and O viruses.

Authors:  Hernando Duque; Barry Baxt
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

Review 10.  Metastasis review: from bench to bedside.

Authors:  Ali Mohammad Alizadeh; Sadaf Shiri; Sadaf Farsinejad
Journal:  Tumour Biol       Date:  2014-08-08
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.